http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005187181-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 |
| filingDate | 2005-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffbbe75c8e008d0a2aab2d8df335a463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_153cf20a32327818a70f5e0bd0aa4e82 |
| publicationDate | 2005-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005187181-A1 |
| titleOfInvention | Use of purine nucleosides to stimulate Na/K ATPase and to treat or prevent shock |
| abstract | This invention relates to methods of treating or preventing hemorrhagic and septic shock in an animal by administering inosine, guanosine, deoxyinosine, deoxyguanosine or a mixture thereof. Other purine nucleosides or analogs are described that have therapeutic use in treating or preventing shock. The invention also describes methods for increasing Na/K ATPase activity in erythrocytes or other cells in an animal having below normal activity of this enzyme by administering inosine, guanosine, deoxyinosine, deoxyguanosine or a mixture thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008005429-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009142797-A1 |
| priorityDate | 2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 312.